Key facts
- This page summarizes Tadd S. Wessel's Form 4 filing for PALVELLA THERAPEUTICS, INC. (PVLA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 11 Jun 2025, 20:00.
Tadd S. Wessel - 10 Jun 2025 Form 4 Insider Report for PALVELLA THERAPEUTICS, INC. (PVLA)
- Reporting relationship
- Director
- Issuer ticker
- PVLA
- Reported as of
- 10 Jun 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Jun 2025, 20:00:08 UTC
- Prior SEC filing
- 16 Dec 2024
- Next SEC filing
- 12 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- By: Kathleen A. McGowan For: Tadd S. Wessel
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Tadd S. Wessel filed Form 4 for PALVELLA THERAPEUTICS, INC. (PVLA) on 11 Jun 2025.
Change
- Previous filing in this sequence was filed on 16 Dec 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002048706
Primary reporting owner
Wessel Tadd S.
- Relationship
- Director
- Address
- C/O PALVELLA THERAPEUTICS, INC., 125 STRAFFORD AVENUE, SUITE 360, WAYNE
- Signature
- By: Kathleen A. McGowan For: Tadd S. Wessel
- Signature date
- 11 Jun 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PVLA
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +12,350
- Change %
- Price
- $0.000000
- Shares after
- 12,350
- Date
- 10 Jun 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,350
- Exercise price
- $26.23
* marks a reported price that did not pass the local price check.